SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014854
Filing Date
2023-08-14
Accepted
2023-08-14 16:16:03
Documents
105
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fbio-20230630x10q.htm   iXBRL 10-Q 4108238
2 EX-31.1 fbio-20230630xex31d1.htm EX-31.1 13874
3 EX-31.2 fbio-20230630xex31d2.htm EX-31.2 14558
4 EX-32.1 fbio-20230630xex32d1.htm EX-32.1 8181
5 EX-32.2 fbio-20230630xex32d2.htm EX-32.2 8118
  Complete submission text file 0001558370-23-014854.txt   15782532

Data Files

Seq Description Document Type Size
6 EX-101.SCH fbio-20230630.xsd EX-101.SCH 106804
7 EX-101.CAL fbio-20230630_cal.xml EX-101.CAL 90235
8 EX-101.DEF fbio-20230630_def.xml EX-101.DEF 467545
9 EX-101.LAB fbio-20230630_lab.xml EX-101.LAB 764332
10 EX-101.PRE fbio-20230630_pre.xml EX-101.PRE 689242
99 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20230630x10q_htm.xml XML 3005339
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 231170416
SIC: 2834 Pharmaceutical Preparations